Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. (SHA:688076)
China flag China · Delayed Price · Currency is CNY
41.30
+0.11 (0.27%)
Sep 29, 2025, 3:00 PM CST

SHA:688076 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202015 - 2019
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Net Income
487.28404.39162.94129.11115.39123.44
Upgrade
Depreciation & Amortization
252.85209.29135.5599.9684.7770.71
Upgrade
Other Amortization
9.497.734.614.724.256.41
Upgrade
Loss (Gain) From Sale of Assets
-0.5-0.5-0.18-18.89-0.063.82
Upgrade
Asset Writedown & Restructuring Costs
8.219.715.30.452.310.3
Upgrade
Loss (Gain) From Sale of Investments
-1.941.72-3.16-19.98-3.22-6.43
Upgrade
Provision & Write-off of Bad Debts
12.2320.625.115.871.651.84
Upgrade
Other Operating Activities
74.6858.164929.6315.4415.8
Upgrade
Change in Accounts Receivable
-235.73-348.97-126.49-145.04-45.88-42.32
Upgrade
Change in Inventory
-325.17-243.29-82.58-111.74-87.63-73.43
Upgrade
Change in Accounts Payable
266.22291.17180.3858.3475.8230.26
Upgrade
Change in Other Net Operating Assets
15.9632.6323.31.718.777.02
Upgrade
Operating Cash Flow
517.84400.12350.2129.29180.75141.38
Upgrade
Operating Cash Flow Growth
37.77%14.25%1095.59%-83.79%27.84%206.44%
Upgrade
Capital Expenditures
-1,449-1,090-660.64-438.36-233.36-111.28
Upgrade
Sale of Property, Plant & Equipment
3.123.981.530.060.3411.46
Upgrade
Divestitures
---13.12-17
Upgrade
Investment in Securities
3.96-308-6-25.95-7-80.76
Upgrade
Other Investing Activities
1.570.952.91.393.090.41
Upgrade
Investing Cash Flow
-1,440-1,393-662.21-449.74-236.93-163.18
Upgrade
Short-Term Debt Issued
----242.68-
Upgrade
Long-Term Debt Issued
-1,6981,146388.99-291.38
Upgrade
Total Debt Issued
2,3321,6981,146388.99242.68291.38
Upgrade
Short-Term Debt Repaid
-----422.79-
Upgrade
Long-Term Debt Repaid
--901.76-454.73-129.65-4.11-242.83
Upgrade
Total Debt Repaid
-1,339-901.76-454.73-129.65-426.91-242.83
Upgrade
Net Debt Issued (Repaid)
993.39796.43691.05259.34-184.2348.55
Upgrade
Issuance of Common Stock
12.5322.98--762.63-
Upgrade
Common Dividends Paid
-225.32-118.75-57.61-40.57-6.04-
Upgrade
Dividends Paid
-225.32-118.75-57.61-40.57-6.04-
Upgrade
Other Financing Activities
99.8899.1-1.5418.15-37.47-9.04
Upgrade
Financing Cash Flow
880.49799.75631.9236.91534.8939.5
Upgrade
Foreign Exchange Rate Adjustments
5.68.34-3.21-0.82-1.58-7.73
Upgrade
Net Cash Flow
-36.26-184.98316.69-184.35477.139.98
Upgrade
Free Cash Flow
-930.99-690.01-310.43-409.07-52.6130.1
Upgrade
Free Cash Flow Margin
-50.55%-42.47%-30.04%-62.81%-8.17%5.31%
Upgrade
Free Cash Flow Per Share
-3.02-2.24-1.03-1.38-0.200.13
Upgrade
Cash Interest Paid
-----11.63
Upgrade
Cash Income Tax Paid
1.818.568.2-29.3-11.18-7.26
Upgrade
Levered Free Cash Flow
-971.29-856.88-374.23-441.9-133.86-70.96
Upgrade
Unlevered Free Cash Flow
-941.42-835.17-364.18-436.11-130.04-63.69
Upgrade
Change in Working Capital
-324.47-311-18.95-201.59-39.78-74.51
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.